We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Endpoints the Focus of Combination Product Guidance
Endpoints the Focus of Combination Product Guidance
July 25, 2007
The FDA identifies meaningful clinical trial endpoint measures in new draft guidance on preparing investigational device exemption (IDE) and investigational new drug (IND) applications for combination products used to repair knee cartilage.